Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8667 |
High Similarity |
NPD1653 |
Approved |
0.8662 |
High Similarity |
NPD5124 |
Phase 1 |
0.8662 |
High Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8378 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.8344 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8221 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8153 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8071 |
Intermediate Similarity |
NPD1091 |
Approved |
0.8 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7964 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7962 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7943 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7925 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7888 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7844 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7823 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7798 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7751 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7725 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7718 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7716 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7706 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7688 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7687 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7679 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7662 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7658 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7643 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7628 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7619 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7593 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7584 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7531 |
Intermediate Similarity |
NPD37 |
Approved |
0.753 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD3750 |
Approved |
0.75 |
Intermediate Similarity |
NPD4966 |
Approved |
0.75 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7583 |
Approved |
0.75 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7485 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7459 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7457 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7457 |
Intermediate Similarity |
NPD8313 |
Approved |
0.745 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7442 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7439 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7413 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.741 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD3748 |
Approved |
0.74 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7396 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7396 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7389 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7384 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7362 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7338 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7338 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD2415 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7301 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7294 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7261 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7248 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD7843 |
Approved |
0.723 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7222 |
Intermediate Similarity |
NPD920 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7209 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7197 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7197 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7194 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7191 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7191 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7191 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.719 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7179 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7176 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7134 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7123 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7122 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7122 |
Intermediate Similarity |
NPD290 |
Approved |
0.7118 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7113 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7108 |
Intermediate Similarity |
NPD4433 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7099 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7089 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7089 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7081 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD4626 |
Approved |
0.707 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7068 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7041 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7039 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7037 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD4140 |
Approved |
0.703 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7013 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD919 |
Approved |
0.6994 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6994 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD1933 |
Approved |
0.6978 |
Remote Similarity |
NPD9697 |
Approved |
0.6977 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6975 |
Remote Similarity |
NPD6667 |
Approved |
0.6975 |
Remote Similarity |
NPD6666 |
Approved |
0.6968 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6963 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6962 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6959 |
Remote Similarity |
NPD5126 |
Approved |
0.6959 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6957 |
Remote Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD1511 |
Approved |
0.6929 |
Remote Similarity |
NPD3134 |
Approved |
0.6923 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD6190 |
Approved |
0.6908 |
Remote Similarity |
NPD3266 |
Approved |
0.6908 |
Remote Similarity |
NPD3267 |
Approved |
0.6903 |
Remote Similarity |
NPD7985 |
Registered |
0.6898 |
Remote Similarity |
NPD6782 |
Approved |
0.6898 |
Remote Similarity |
NPD6780 |
Approved |
0.6898 |
Remote Similarity |
NPD6779 |
Approved |
0.6898 |
Remote Similarity |
NPD6778 |
Approved |
0.6898 |
Remote Similarity |
NPD6781 |
Approved |
0.6898 |
Remote Similarity |
NPD6777 |
Approved |
0.6898 |
Remote Similarity |
NPD6776 |
Approved |
0.689 |
Remote Similarity |
NPD2533 |
Approved |
0.689 |
Remote Similarity |
NPD2534 |
Approved |
0.689 |
Remote Similarity |
NPD2532 |
Approved |
0.6882 |
Remote Similarity |
NPD3882 |
Suspended |
0.6879 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6868 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD3705 |
Approved |
0.6863 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6859
|
Remote Similarity |
NPD4062 |
Phase 3 |